Difference between revisions of "Myeloproliferative neoplasms"
Jump to navigation
Jump to search
m (→References) |
m (→Grouping: fix spell.) |
||
| Line 3: | Line 3: | ||
==Grouping== | ==Grouping== | ||
They include the following:<ref name=pmid15781101>{{cite journal |author=Baxter EJ, Scott LM, Campbell PJ, ''et al.'' |title=Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders |journal=Lancet |volume=365 |issue=9464 |pages=1054–61 |year=2005 |pmid=15781101 |doi=10.1016/S0140-6736(05)71142-9 |url=}}</ref> | They include the following:<ref name=pmid15781101>{{cite journal |author=Baxter EJ, Scott LM, Campbell PJ, ''et al.'' |title=Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders |journal=Lancet |volume=365 |issue=9464 |pages=1054–61 |year=2005 |pmid=15781101 |doi=10.1016/S0140-6736(05)71142-9 |url=}}</ref> | ||
* | *Polycythemia vera. | ||
*Essential thrombocythaemia. | *Essential thrombocythaemia. | ||
*Idiopathic myelofibrosis. | *Idiopathic myelofibrosis. | ||